RAINBOW ABC
DEAD

Serial Number

76113580

Owner

EPIGENESIS Pharmaceuticals, Inc.

Attorney

Dr. Viviana Amzel

Filing Date

Aug 16, 2000

Add to watchlist:

No watchlists yet
View on USPTO

RAINBOW ABC Trademark

Serial Number: 76113580

RAINBOW ABC is a trademark filed by EPIGENESIS Pharmaceuticals, Inc. on August 16, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Trademark Details

Filing Date

August 16, 2000

Registration Date

Not Registered

Published for Opposition

December 3, 2002

Goods & Services

aerosol dispensers for medical use, sold filled or in a kit with, and for the delivery of pharmaceutical preparations for use in testing, and prophylactic and therapeutic treatment, of ailments, diseases and conditions associated with respiratory, airway and pulmonary diseases, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, for example when associated with ischemia, administration of certain drugs, in heart and cardiovascular stress tests, side effects associated with adenosine and other compounds, such as when treating Supra Ventricular Tachycardia (SVT), infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers such as leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinomas, kidney cancer, melanoma, hepatic metastases, etc., as well as other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate, airway diseases and conditions including those that may be associated with hyper-sensitivity or hyer-responsiveness to adenosine, bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and /or inflammation, which in many cases are adenosine receptor associated symptoms, and more generally for testing and treatment of human and non-human animal ailment included

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2003 NOAM
PUBLISHED FOR OPPOSITION
Dec 3, 2002 PUBO
NOTICE OF PUBLICATION
Nov 13, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2002 CRFA
PAPER RECEIVED
Aug 19, 2002 MAIL
Sec. 1(B) CLAIM ADDED
Jul 17, 2002 1.BA
SEC. 1(A) CLAIM DELETED
Jul 17, 2002 1.AD
NON-FINAL ACTION MAILED
Jul 17, 2002 CNRT
LETTER OF SUSPENSION MAILED
Oct 31, 2001 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2001 CRFA
NON-FINAL ACTION MAILED
Feb 1, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 4, 2001 DOCK